-
Scipher Medicine Leadership to Present at the 40th Annual J.P. Morgan Healthcare Conference -
Scipher Medicine Appoints Richard Blackburn to its Advisory Board -
Nearly 15% of Prescribing U.S. Rheumatologists Use Scipher Medicine’s PrismRA Blood Test Since Its Launch A Year Ago -
Scipher Medicine Appoints Dr. Michael Elliott to its Science Advisory Board - America’s Choice Provider Network Partners with Scipher Medicine to Improve Patient Outcomes and Lower Costs for Rheumatoid Arthritis Care
-
Scipher Medicine® Appoints Sam Asgarian, M.D., MBA, Chief Medical Officer -
RxParadigm Partners with Scipher Medicine® to Support Medication Utilization, Improve Patient Outcomes, and Lower Costs for Rheumatoid Arthritis Care -
Scipher Medicine® to Present at the Jeffries London Healthcare Conference - Scipher Medicine® to Present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
-
GNS Healthcare and Scipher Medicine® Collaborate to Develop World’s First in silico Patient for Rheumatoid Arthritis -
TARA Biosystems Partners with Scipher Medicine® -
Trellis Rx Furthers Commitment to Advancing the Specialty Pharmacy Practice and Patient Outcomes with Integration of Scipher Medicine® PrismRA® Precision-Medicine Technology into Clinical Pathways -
Scipher Medicine Strengthens Leadership Team with Appointment of Sam A Davis, JD as General Counsel -
Scipher Medicine Welcomes John Strumbos as Chief Financial Officer -
Scipher Medicine Welcomes Chip Parkinson as Chief Commercial Officer of its Diagnostics Business